influenza
flu
contagi
febril
viral
diseas
often
accompani
inflamm
upper
lower
respiratori
tract
myalgia
gastrointestin
disord
neurolog
disord
headach
prostrat
insomnia
influenza
may
lead
bronchiti
pneumonia
hospit
death
particularli
highrisk
elderli
peopl
live
nurs
home
influenza
caus
virus
belong
orthomyxoviru
group
famili
orthomyxovirida
ortho
true
myxo
affin
mucoprotein
nayak
influenza
virus
iv
envelop
segment
negativestrand
rna
virus
contain
helic
nucleocapsid
also
call
ribonucleoprotein
rnp
iv
particl
usual
spheric
approxim
nm
diamet
figur
b
b
although
particl
filament
segment
figur
c
c
viru
envelop
mosaic
lipid
bilay
contain
spike
outsid
matrix
protein
insid
spike
hemagglutinin
ha
neuraminidas
na
anchor
lipid
bilay
genet
materi
genom
iv
consist
singl
negativestrand
rna
segment
complex
nucleoprotein
np
form
rnp
viru
genom
contain
eight
distinct
rna
segment
seven
rna
segment
influenza
c
viru
encod
least
one
sometim
two
protein
viral
rna
neg
polar
minu
strand
ie
opposit
polar
mrna
function
templat
protein
synthesi
viral
mrna
posit
polar
made
infect
serv
templat
protein
synthesi
therefor
infecti
iv
particl
must
carri
rnadepend
rna
polymeras
rdrp
transcriptas
replicas
nake
iv
rna
infecti
rdrp
heterotrim
pa
protein
complex
replic
transcript
viral
rna
occur
insid
nucleu
infect
cell
wherea
assemblybud
lead
virion
format
take
place
plasma
membran
figur
complet
viru
particl
found
insid
infect
cell
iv
divid
three
type
name
influenza
type
type
b
type
c
base
immunolog
biolog
properti
type
b
virus
possess
eight
rna
segment
wherea
type
c
virus
possess
seven
rna
segment
type
specif
base
antigen
natur
two
major
intern
antigen
np
matrix
protein
serolog
specif
determin
complement
fixat
assay
enzymelink
immunosorb
assay
elisa
type
virus
similar
np
protein
differ
type
b
type
c
virus
howev
current
nucleic
acid
assay
includ
polymeras
chain
reaction
pcr
genom
sequenc
use
identifi
type
subtyp
specif
well
subtl
differ
among
viru
strain
includ
genet
mutat
predict
evolutionari
pathogen
behavior
subtyp
specif
determin
serolog
natur
major
envelop
antigen
name
ha
na
differ
subtyp
occur
among
influenza
type
virus
found
human
warmblood
anim
accord
present
nomenclatur
ha
subtyp
na
subtyp
found
among
influenza
type
virus
includ
newli
discov
iv
peruvian
bat
tong
et
al
individu
viru
isol
identifi
subtyp
specif
eg
etc
denot
ha
subtyp
na
subtyp
possibl
combin
three
subtyp
known
caus
human
epidem
pandem
appar
reason
restrict
subtyp
specif
human
clear
although
receptor
specif
human
respiratori
epitheli
cell
may
contribut
factor
influenza
type
b
type
c
virus
found
human
exhibit
subtyp
variat
caus
milder
diseas
compar
type
virus
usual
iv
speci
specif
caus
epidem
ie
iv
pig
caus
epidem
pig
human
although
infect
speci
limit
way
exampl
farmer
work
anim
found
possess
antibodi
chicken
swine
equin
virus
indic
infect
virus
recent
year
highli
pathogen
avian
virus
spread
among
human
infect
caus
fatal
diseas
human
epidemiolog
natur
diseas
possibl
emerg
new
pandem
virus
world
health
organ
collabor
nation
organ
center
diseas
control
cdc
nation
cryoet
udorn
particl
without
rnp
spheroid
iv
particl
without
rnp
core
vari
height
z
direct
box
ii
show
particl
rnp
vari
height
rnp
found
throughout
particl
contrast
box
iii
iv
show
particl
without
rnp
core
vari
height
electrondens
rnp
found
throughout
entir
particl
bar
nm
c
rnp
distribut
filament
particl
two
differ
filament
virus
show
electron
dens
rnp
red
arrow
throughout
particl
insid
bar
nm
institut
health
other
throughout
world
organ
worldwid
influenza
surveil
program
consequ
vast
number
iv
strain
isol
everi
year
human
varieti
anim
speci
includ
chicken
duck
pig
hors
migratori
duck
waterfowl
often
promiscu
infect
mani
subtyp
iv
thu
serv
reservoir
genet
reassort
spread
iv
uniform
system
nomenclatur
follow
identifi
isol
includ
type
specif
virusplac
isolationisol
numberyear
isol
accompani
subtyp
specif
applic
exampl
apuerto
figur
schemat
illustr
influenza
viru
infecti
cycl
schemat
diagram
show
attach
entri
uncoat
attach
mediat
ha
red
sa
receptor
entri
cell
via
endosom
hamedi
fusion
viru
endosom
membran
low
ph
releas
rnp
transport
rnp
nucleu
transcript
mrna
synthesi
replic
crna
vrna
synthesi
rnp
nucleu
b
schemat
represent
nuclear
exit
rnp
transport
assembl
viral
compon
plasma
membran
bud
influenza
viru
c
viru
bud
cell
surfac
et
hpi
wsninfect
mdck
cell
process
thin
section
examin
et
pictur
repres
one
slice
inner
core
viru
bud
parallel
arrang
rnp
insid
bud
perpendicular
cell
surfac
seen
bud
neck
show
gap
indic
possibl
absenc
ha
na
spike
seen
bud
envelop
reproduc
nayak
dp
balogun
ra
yamada
h
hong
zhou
h
barman
influenza
viru
morphogenesi
bud
viru
re
permiss
bgreat
older
prototyp
strain
person
name
use
instead
place
isol
sometim
isol
number
miss
eg
howev
present
nomenclatur
system
fail
identifi
epidemiolog
behavior
host
origin
human
swine
equin
chicken
duck
gener
iv
envelop
particl
surfac
project
spike
pleomorph
roughli
spheroid
nm
diamet
figur
filament
mm
longer
figur
c
c
schemat
present
typic
spheroid
iv
shown
figur
usual
laboratori
adapt
virus
virus
exhibit
spheroidalellipsoid
morpholog
figur
b
b
wherea
fresh
field
isol
filament
howev
viru
strain
exhibit
elongatedfilament
morpholog
figur
c
c
even
mani
passag
laboratori
viru
morpholog
examin
transmiss
figur
scan
electron
microscopi
figur
b
c
recent
cryoelectron
tomographi
cryoet
figur
cryoet
use
examin
surfac
intern
content
frozen
hydrat
viru
particl
nativ
state
reconstruct
threedimension
structur
figur
combin
differ
tilt
imag
particl
cryoet
analys
show
presenc
approxim
ha
nm
triangular
shape
na
nm
squar
shape
spike
surfac
spheroid
particl
harri
et
al
rnp
core
noda
kawaoka
influenza
virion
possess
three
subvir
compon
name
envelop
matrix
layer
underneath
lipid
bilay
rnp
core
figur
envelop
influenza
viru
consist
lipid
bilay
contain
three
viral
encod
transmembran
tm
protein
ha
na
outsid
underneath
membran
lipid
bilay
mosaic
contain
cholesterolenrich
lipid
raft
nonraft
lipid
select
deriv
host
cell
membran
ha
na
anchor
lipid
raft
wherea
although
cholesterolbind
protein
associ
nonraft
lipid
ha
major
envelop
protein
form
trimer
spike
receptorbind
site
epitop
neutral
antibodi
na
second
abund
envelop
protein
form
mushroomlik
tetramer
spike
na
remov
cell
surfac
sialic
acid
sa
receptor
play
critic
role
releas
progeni
viru
particl
third
envelop
protein
tetram
proton
select
ion
channel
although
minor
compon
moleculesvirion
play
critic
role
disassembl
well
viru
releas
section
infecti
cycl
ha
polypeptid
influenza
type
b
possess
around
amino
acid
aa
respect
influenza
c
viru
singl
transmembran
protein
aa
possess
receptorbind
hemagglutin
receptordestroy
esteras
activ
refer
protein
ha
type
tm
glycoprotein
ntermin
signal
sequenc
remov
signal
peptidas
transloc
endoplasm
reticulum
er
therefor
absent
matur
ha
ctermin
hydrophob
domain
function
transmembran
domain
tmd
anchor
protein
lipid
bilay
ha
cleav
intern
hydrophob
domain
gener
held
togeth
disulfid
bond
hydrophob
domain
becom
nterminu
cleavag
host
cell
proteas
depend
occur
transport
ha
membran
traffick
pathway
cleavag
ha
requir
intracellular
transport
matur
trimmer
format
glycosyl
assembl
bud
viru
particl
bind
entri
hemagglutin
howev
cleavag
ha
free
nterminu
critic
viru
infect
fusion
viru
endosom
membran
low
ph
section
infecti
cycl
viru
particl
contain
uncleav
ha
infecti
although
bind
cell
receptor
intern
endosom
vitro
treatment
iv
particl
contain
uncleav
ha
proteas
trypsin
gener
render
noninfecti
particl
infecti
sequenc
specif
cleavag
peptid
junction
hal
vari
differ
virus
mani
structur
featur
conserv
among
found
differ
viru
isol
presenc
multipl
basic
residu
like
arginin
lysin
render
ha
highli
cleavabl
furinlik
host
proteas
ha
contain
number
nlink
oligosaccharid
number
locat
composit
vari
differ
subtyp
even
among
differ
strain
subtyp
oligosaccharid
provid
structur
stabil
protect
host
proteas
play
import
role
immunemodul
epidem
virus
ha
present
viru
particl
surfac
virusinfect
cell
ha
bind
erythrocyt
caus
hemagglutin
hemadsorpt
assay
use
quantif
viru
particl
virusinfect
cell
respect
trimer
ha
spike
rod
shape
structur
ha
spike
show
two
distinct
structur
domain
triplestrand
coil
coil
fibrou
stalk
extend
viral
cellular
membran
globular
head
distal
end
stalk
consist
eightstrand
b
sheet
possess
receptor
bind
site
major
epitop
neutral
antibodi
fibrou
stem
possess
terminu
requir
uncoat
infect
see
nayak
nayak
nayak
nayak
na
also
known
sialidas
ec
exoglycosidas
cleav
sa
nacetylneuramin
acid
glycan
remov
sa
receptor
na
type
ii
membran
protein
possess
singl
extend
hydrophob
domain
nterminu
protein
transloc
across
er
anchor
lipid
bilay
tetramer
na
spike
exhibit
mushroomlik
oblong
head
attach
fibrou
stalk
monomer
head
consist
six
propellerlik
fourstrand
antiparallel
b
sheet
counterclockwis
order
contain
enzymat
catalyt
site
larg
depress
top
head
therefor
na
spike
possess
four
catalyt
site
apart
nayak
na
also
contain
four
six
nlink
oligosaccharid
vari
differ
na
subtyp
type
c
viru
protein
provid
ha
na
function
na
facilit
viru
releas
infect
cell
play
import
role
viru
spread
virul
host
specif
antibodi
na
directli
neutral
viru
particl
significantli
reduc
viru
pathogen
restrain
viru
spread
within
host
popul
antivir
agent
like
oseltamivir
tamiflu
roch
zanamivir
relenza
glaxosmithklin
interfer
na
function
type
b
viru
na
mrna
segment
also
encod
anoth
protein
nb
aa
present
virusinfect
cell
viru
particl
known
function
small
protein
aa
homotetram
function
proton
channel
tm
type
ii
protein
singl
signalanchor
domain
unlik
na
nterminu
cterminu
encod
splice
mrna
segment
seven
rna
although
molecul
present
viru
envelop
function
proton
channel
play
critic
role
uncoat
process
infect
section
infecti
cycl
affect
host
rang
viru
bud
critic
function
antivir
agent
amantadin
rimantadin
abund
protein
virion
present
electron
dens
layer
underneath
viral
membran
form
critic
bridg
viral
envelop
rnp
core
interact
cytoplasm
tail
ha
na
outer
side
vrna
np
inner
side
lipidbind
protein
play
critic
role
mani
stage
viru
replic
includ
regul
uncoatingdisassembl
nuclear
import
export
viral
rnp
transcript
replic
viral
genom
final
transport
assembl
rnp
viru
morphogenesi
bud
core
iv
particl
call
nucleocapsid
ribonucleoprotein
figur
b
c
viru
core
consist
helic
rnp
segment
contain
negativestrand
vrna
eight
separ
rna
segment
influenza
b
seven
rna
segment
iv
c
np
along
minor
amount
nuclear
export
protein
nep
complex
influenza
rna
segment
rang
approxim
kb
largest
one
encod
polymeras
protein
pa
smallest
one
encod
nonstructur
protein
viral
rna
segment
possess
similar
sequenc
well
termini
partial
complementari
form
partial
doublestrand
panhandl
stem
function
regul
transcript
replic
vrna
rnp
wrap
around
np
scaffold
expos
outsid
glide
interact
complex
transcriptionrepl
viru
particl
complex
present
one
end
rnp
requir
primer
transcript
initi
indic
transcript
inact
rnp
export
nucleu
packag
virion
purifi
rnp
possess
twist
rodlik
structur
fold
back
coil
nm
diamet
vari
length
nm
depend
size
vrna
segment
noda
kawaoka
tao
zheng
np
basic
protein
provid
scaffold
function
rna
templat
transcript
replic
activ
synthesi
np
requir
replic
viral
rna
transcript
mrna
complex
also
call
transcriptas
replicas
rdrp
rna
depend
rna
polymeras
consist
three
protein
pa
three
largest
viral
protein
approxim
aa
encod
three
largest
viral
rna
segment
complex
function
transcript
replic
viral
rna
molecul
complex
present
infecti
viru
particl
transcript
replic
iv
rna
occur
insid
nucleu
infect
cell
polymeras
protein
possess
nuclear
local
signal
activ
transport
nucleu
nuclear
pore
two
ns
protein
encod
smallest
rna
segment
segment
found
virusinfect
cell
transport
nucleu
implic
inhibit
host
mrna
synthesi
nuclear
export
viral
mrna
translat
viral
protein
found
viru
particl
play
critic
role
viru
virul
counteract
function
host
interferon
howev
misnom
sinc
found
viru
particl
appropri
call
nep
play
critic
role
nuclear
exit
viral
rnp
cytoplasm
eventu
transport
bud
site
hand
nb
protein
encod
segment
six
rna
encod
na
influenza
b
virusinfect
cell
found
iv
particl
therefor
classifi
ns
protein
similarli
small
aa
protein
express
mrna
altern
read
frame
caus
apoptosi
macrophag
present
mani
influenza
viru
strain
howev
role
virul
pathogenesi
influenza
epidem
pandem
remain
unclear
influenza
viru
genom
encod
protein
ha
na
np
nsnep
pa
pax
although
protein
encod
rna
iv
infecti
cycl
involv
attach
adsorpt
entri
fusion
uncoat
transcript
replic
viral
rna
translat
viral
protein
transport
assembl
viral
protein
vrnp
bud
viru
particl
figur
first
step
viru
life
cycl
viru
attach
mediat
interact
ligand
ha
cell
surfac
receptor
sa
cell
surfac
sa
receptorbind
site
ha
vari
among
differ
viru
strain
vari
affin
ha
sa
receptor
play
critic
role
speci
specif
zoonos
pathogenesi
transmiss
pandem
behavior
iv
strain
cell
surfac
bind
virion
enter
cell
via
receptormedi
endocytosi
major
iv
use
clathrinco
pit
ccp
remaind
use
clathrinindepend
vesicl
entri
pathway
lead
viral
fusion
endosom
membran
similar
effici
howev
iv
use
preexist
ccp
form
de
novo
ccp
attach
site
viru
bind
form
de
novo
ccp
remain
unclear
like
local
membran
curvatur
caus
multival
bind
spheric
viru
particl
cell
surfac
attract
bar
domain
amphiphysin
promot
ccp
format
filament
virus
enter
cell
via
micropinocytosi
use
nonclathrin
noncaveola
dynaminindepend
endocytosi
na
coevolv
receptor
specif
ha
although
na
requir
viru
attach
entri
facilit
infect
ciliat
respiratori
epithelium
vivo
releas
viru
particl
mucin
rich
sa
cover
respiratori
mucosa
viru
entri
dynam
process
involv
attach
elut
na
affect
dynam
entri
process
caus
viru
elut
viru
particl
get
insid
endosom
na
littl
role
entri
follow
attachmententri
virion
must
undergo
uncoatingdisassembl
acid
environ
endosom
ph
separ
two
major
step
fusion
viral
endosom
membran
releas
rnp
step
iv
life
cycl
schemat
shown
figur
vesicl
held
togeth
close
proxim
local
destabil
occur
mix
membran
lipid
caus
fusion
form
singl
vesicl
howev
iv
bind
cell
surfac
sa
via
ha
endocytos
distanc
viru
endosom
membran
far
great
fusion
ha
major
barrier
must
undergo
conform
chang
fusion
occur
two
condit
necessari
ha
must
cleav
present
acid
environ
ph
ha
cleavag
gener
glycinerich
hydrophob
fusion
peptid
aa
nterminu
neutral
ph
remain
buri
nativ
molecul
globular
head
acid
ph
endosom
convert
ha
metast
state
caus
fusion
peptid
project
upward
insert
target
endosom
membran
still
distanc
endosom
viral
membran
remain
around
final
stem
ha
spike
splay
apart
bring
viral
endosom
lipid
bilay
close
fusion
lead
format
hemifus
state
outer
layer
lipid
bilay
undergo
mix
without
mix
inner
content
subsequ
layer
lipid
bilay
fuse
pore
form
mix
content
vesicl
six
ha
trimer
requir
format
fusion
pore
furthermor
fusion
peptid
nterminu
cterminu
tmd
directli
interact
glycin
ridg
ntermin
arm
fusion
peptid
import
helixhelix
interact
tmd
low
phinduc
structur
chang
ha
fusion
process
irrevers
low
ph
treatment
weaken
bond
render
viral
envelop
pliabl
facilit
fusion
see
nayak
et
al
disrupt
interact
acid
ph
releas
rnp
cytoplasm
transport
nucleu
proton
channel
remain
close
neutral
ph
open
acid
ph
endosom
acidifi
virioninterior
releas
vrnp
cytoplasm
rnp
transport
host
nucleu
nuclear
pore
complex
transcript
replic
vrna
membran
fusion
rnp
releas
acid
ph
highli
coordin
otherwis
rnp
becom
trap
releas
cytoplasm
block
ion
channel
drug
like
amantadin
rimantadin
increas
endosom
ph
prevent
viru
uncoat
viru
replic
follow
disassembl
complex
transport
nucleu
infect
cell
nuclear
pore
help
nuclear
local
signal
present
polymeras
np
protein
three
type
rna
found
ivinfect
cell
vrna
strand
viral
rna
crna
complet
strand
rna
use
templat
vrna
synthesi
mrna
strand
use
translat
virusencod
protein
nucleu
first
event
transcript
plu
strand
viral
mrna
complex
minu
strand
vrna
templat
primari
transcript
howev
iv
transcript
uniqu
process
sinc
polymeras
initi
de
novo
transcript
requir
primer
transcript
initi
complex
snatch
cap
host
premrna
nucleu
use
primer
viral
mrna
transcript
complex
bind
cap
host
premrna
endonucleas
activ
pa
cleav
rna
cap
initi
viral
transcript
therefor
viral
mrna
contain
end
cap
oligonucleotid
base
deriv
host
mrna
follow
bodi
mrna
complementari
second
nucleotid
vrna
lack
last
nucleotid
possess
poli
track
end
nayak
unlik
mrna
transcript
vrna
replic
involv
synthesi
complet
full
length
strand
rna
crna
without
either
cap
host
mrna
primer
end
poli
track
end
crna
strand
use
templat
vrna
strand
synthesi
switch
mrna
fulllength
crna
synthesi
requir
continu
synthesi
np
thu
np
provid
scaffold
function
present
templat
rna
complex
antitermin
function
full
length
rna
chain
complet
vrna
synthesi
also
coupl
np
bind
nascent
vrna
rnp
translat
viral
protein
mrna
continu
high
rate
throughout
infecti
cycl
although
mrna
synthesi
greatli
diminish
late
phase
infect
protein
ml
np
synthes
free
cytoplasm
polysom
wherea
tm
protein
like
ha
na
nb
synthes
membranebound
polysom
tm
protein
follow
traffick
pathway
host
tm
protein
glycosyl
transport
ha
na
form
complex
trimer
ha
tetram
na
er
membran
export
golgi
complex
plasma
membran
iv
passag
high
multipl
infect
defect
interf
di
viru
also
call
von
magnu
particl
gener
di
particl
contain
shorter
vrna
di
rna
gener
primarili
intern
delet
three
largest
vrna
segment
encod
protein
di
particl
infecti
need
helper
function
infecti
particl
replic
therefor
di
particl
replic
cell
coinfect
infecti
particl
turn
interfer
becom
predomin
particl
expens
infecti
particl
iv
particl
releas
environ
bud
cellular
membran
nonpolar
cell
apic
plasma
membran
polar
epitheli
cell
complet
viru
particl
found
insid
infect
cell
therefor
viru
compon
brought
bud
site
assembl
bud
initi
bud
matur
releas
figur
b
c
howev
step
rather
continuum
without
strong
stopstart
checkpoint
ie
complet
previou
step
requir
initi
next
step
assembl
viral
compon
subvir
complex
occur
either
transport
bud
bud
initi
occur
compon
brought
bud
site
even
bud
releas
occur
absenc
complet
set
rnp
without
rnp
figur
b
iii
iv
assembl
bud
three
subvir
compon
name
viral
envelop
ha
na
rnp
brought
bud
site
ie
apic
plasma
membran
polar
epitheli
cell
howev
determin
apic
membran
bud
site
remain
unclear
although
iv
particl
possess
three
tm
envelop
protein
ha
na
apic
determin
suffici
select
apic
bud
site
viral
compon
particularli
nprnp
may
play
import
role
select
bud
site
nayak
et
al
nayak
et
al
nayak
et
al
sinc
rnp
synthes
nucleu
must
export
brought
bud
site
nep
mediat
nuclear
export
rnp
form
daisychain
complex
rangtp
furthermor
sinc
complex
found
one
end
rnp
insid
viru
particl
inhibit
transcript
initi
rnp
critic
nuclear
exit
incorpor
rnp
viru
particl
bud
site
modifi
accumul
ha
na
spike
exclud
major
host
cell
membran
protein
patch
subsequ
protein
attract
inner
layer
membran
viral
rnp
accumul
underneath
protein
assembl
site
final
viru
particl
bud
plasma
membran
figur
b
c
infecti
iv
contain
eight
seven
influenza
c
viru
specif
vrna
segment
howev
multipl
rnp
segment
correctli
assembl
viru
particl
remain
unclear
two
model
random
packag
specif
packag
propos
random
packag
model
predict
presenc
common
structur
element
vrna
caus
incorpor
randomli
virion
incorpor
rnp
releas
particl
depend
vrnarnp
concentr
infect
cell
observ
iv
particl
possess
eight
rnp
rna
per
virion
viru
particl
infecti
support
random
packag
hand
specif
packag
model
predict
specif
structur
featur
present
rnarnp
segment
enabl
select
incorpor
virion
support
model
includ
vrna
equimolar
viru
particl
although
vrna
concentr
vari
infect
cell
di
rna
competit
inhibit
packag
normal
counterpart
vrna
recent
studi
number
laboratori
shown
presenc
segmentspecif
packag
signal
eight
rna
segment
incorpor
specif
rna
segment
support
hierarchi
rna
incorpor
serial
section
influenza
viru
infect
mdck
madindarbi
canin
kidney
cell
well
et
analysi
releas
virion
show
rnp
influenza
virus
organ
distinct
pattern
noda
kawaoka
fish
fluoresc
situ
hybrid
analysi
demonstr
presenc
eight
uniqu
rna
segment
major
rnpcontain
viru
particl
chou
et
al
howev
specif
rnarna
interact
form
multisegment
rnp
complex
tran
yet
shown
moreov
iv
particl
without
rnp
seen
figur
b
iii
iv
howev
possibl
segmentspecif
complex
format
incorpor
vrna
complex
occur
affect
bud
releas
ie
rnp
activ
particip
bud
process
passiv
entrap
bud
releas
viru
particl
flu
influenza
outbreak
occur
almost
predict
epidem
fall
end
spring
although
sever
outbreak
vari
year
year
respons
increas
morbid
mortal
econom
loss
billion
dollar
period
sinc
iv
surviv
outsid
host
long
time
sinc
viru
produc
latent
chronic
infect
patient
iv
persist
spread
person
person
evad
host
immun
defens
winter
month
close
persontoperson
contact
indoor
live
increas
viabil
iv
dri
cold
air
facilit
spread
diseas
among
popul
two
uniqu
properti
iv
root
epidem
behavior
high
frequenc
antigen
mutat
one
per
nucleotid
per
infecti
cycl
caus
errorpron
natur
iv
replicas
ineffici
proofread
function
select
resist
virus
host
immun
respons
lead
antigen
drift
annual
epidem
epidem
defin
geograph
limit
outbreak
diseas
human
popul
analys
viru
isol
epidem
shown
new
mutant
virus
continu
emerg
almost
everi
year
although
mutat
occur
eight
viral
rna
segment
select
pressur
host
antibodi
lead
emerg
resist
antigen
variant
five
major
antigen
epitop
globular
head
ha
alter
new
variant
virus
escap
host
immun
respons
elicit
prior
infect
nayak
sinc
minor
antigen
determin
may
alter
sinc
major
human
popul
like
antibodi
progenitor
viru
annual
epidem
produc
antigen
variant
tend
milder
less
widespread
compar
worldwid
pandem
still
influenza
respons
death
everi
year
fall
winter
season
unit
state
alon
particularli
among
elderli
peopl
also
caus
econom
impact
lost
workday
decreas
work
effici
increas
school
absente
hospit
clinic
visit
use
medic
exampl
recent
estim
put
cost
influenza
epidem
economi
unit
state
billion
per
year
molinari
et
al
http
segment
natur
viral
genom
larg
gene
pool
influenza
virus
ha
na
subtyp
human
well
warmblood
anim
bird
facilit
mix
human
nonhuman
viral
gene
provid
unusu
opportun
exchang
viral
gene
reassort
caus
antigen
shift
lead
new
antigen
subtyp
antigen
shift
respons
worldwid
pandem
unlik
season
epidem
global
natur
spread
rapidli
among
human
popul
jet
age
mobil
aid
rapid
spread
viru
last
centuri
three
influenza
pandem
document
spanish
flu
pandem
deadliest
pandem
human
histori
kill
million
peopl
worldwid
includ
unit
state
alon
subsequ
two
pandem
asian
flu
japan
flu
hong
kong
flu
occur
twentieth
centuri
natur
viru
determin
later
antibodi
sera
peopl
afflict
year
sinc
viru
avail
howev
recent
viru
genom
sequenc
tissu
preserv
formalin
frozen
permafrost
viru
recreat
revers
genet
tumpey
et
al
first
pandem
twentyfirst
centuri
declar
analys
pandem
virus
show
pandem
caus
exclus
type
virus
swine
influenzalik
viru
respons
pandem
viru
viru
pandem
pandem
viru
also
known
swine
flu
deriv
mutat
quadrupl
reassort
swine
avian
human
iv
neumann
et
al
figur
howev
viru
antigen
distinct
previou
virus
although
iv
speci
specif
ie
produc
diseas
spread
within
host
speci
caus
diseas
anim
speci
human
known
becom
occasion
infect
anim
iv
eg
farmer
found
antibodi
swine
equin
avian
virus
vice
versa
therefor
occasion
person
anim
becom
infect
time
multipl
virus
eg
human
anim
viru
virus
replic
cell
segment
natur
viral
genom
facilit
gene
reassort
assembl
packag
viral
rnp
viru
bud
caus
emerg
new
virus
contain
rna
segment
differ
virus
new
virus
retain
growth
advantag
human
replac
antigen
determin
old
ha
ha
na
anim
virus
mutat
reassort
facilit
emerg
new
pandem
viru
recent
pandem
viru
emerg
multipl
reassort
mutat
figur
howev
condit
lead
advent
new
pandem
fulli
understood
make
imposs
predict
either
time
natur
next
pandem
viru
recent
avian
virus
caus
high
mortal
infect
human
spread
human
human
great
concern
genet
reassort
two
virus
routin
use
make
current
influenza
vaccin
chicken
embryo
year
newli
isol
candid
viru
predict
caus
epidem
next
year
grown
togeth
highyield
viru
gener
highyield
vaccin
viru
contain
ha
na
new
strain
typic
influenza
acut
ill
often
character
sudden
onset
fever
myalgia
sore
throat
nonproduct
cough
howev
clinic
manifest
influenza
infect
vari
greatli
person
person
mani
host
factor
age
immunolog
statu
ie
prior
exposur
antigen
relat
virus
physiolog
state
infect
person
mani
factor
influenc
sever
diseas
syndrom
infect
may
subclin
ie
asymptomat
produc
mild
symptom
like
fever
cold
caus
acut
prostrat
febril
ill
accompani
gener
respiratori
symptom
may
includ
pharyng
tracheiti
bronchiti
lead
short
breath
cough
myalgia
sever
case
may
lead
primari
viral
pneumonia
accompani
subbronchi
hemorrhag
even
fatal
outcom
incub
period
short
day
onset
sudden
fever
temperatur
f
even
higher
chill
myalgia
young
children
common
symptom
pharyngotracheobronch
croup
even
gastrointestin
disord
typic
flu
adult
fever
may
subsid
day
respiratori
symptom
gener
weak
may
persist
week
diseas
may
sever
young
elderli
patient
patient
preexist
underli
condit
includ
pregnanc
cardiovascular
diseas
respiratori
condit
chronic
bronchiti
chronic
obstruct
pulmonari
diseas
bronchopulmonari
neoplasia
asthma
emphysema
well
patient
immunocompromis
condit
includ
radiat
chemotherapi
nayak
viru
commonli
spread
aerosol
droplet
fingertip
therefor
wash
hand
avoid
contact
infect
person
first
line
defens
spread
flu
although
indoor
live
close
peopl
enclos
environ
winter
season
facilit
viru
transmiss
person
person
lead
epidem
clear
correl
sever
winter
either
frequenc
sever
clinic
diseas
epidem
iv
lytic
usual
establish
chronic
stabl
relationship
infect
cellshost
caus
acut
ill
kill
infect
cell
virul
pathogenesi
iv
depend
abil
grow
kill
cell
particular
tissu
name
respiratori
tract
lead
reduc
function
abil
organ
cell
kill
iv
involv
cleavag
degrad
newli
synthes
cellular
mrna
cap
use
primer
viral
mrna
suppress
synthesi
cellular
protein
modif
plasma
membran
may
contribut
toward
vivo
kill
virusinfect
cell
host
immun
respons
cytotox
cell
apoptosi
infect
cell
induc
number
viru
factor
includ
dsrna
na
multipl
apoptosi
induc
pathway
includ
tumor
necrosi
factorrel
apoptosi
induc
ligand
involv
cell
death
clinic
symptom
includ
sever
diseas
relat
extent
desquam
respiratori
epitheli
cell
site
destruct
ie
upper
respiratori
middl
lower
respiratori
tract
experiment
studi
anim
suggest
influenza
descend
infect
ie
viru
initi
infect
either
upper
respiratori
tracheal
epithelium
later
infect
spread
bronchial
epithelium
even
alveolar
cell
caus
primari
viral
pneumonia
gener
sever
diseas
depend
abil
viru
infect
spread
lower
respiratori
epithelium
includ
bronchiolar
alveolar
cell
hand
spread
among
popul
depend
abil
viru
replic
nasal
upper
respiratori
epithelium
therefor
avian
viru
like
recent
year
although
highli
virul
infect
person
fatal
spread
among
human
viru
grow
effici
upper
lower
respiratori
tract
caus
sever
diseas
spread
effici
natur
sa
receptor
upper
lower
respiratori
cell
vari
differenti
bind
effici
viru
ha
sa
receptor
affect
virul
spread
viru
among
popul
usual
viru
shed
week
sometim
longer
rare
case
persist
pulmonari
diseas
immunocompromis
patient
although
respiratori
symptom
explain
basi
site
extent
viral
patholog
caus
gener
symptom
myalgia
anorexia
malais
gastrointestin
disord
remain
unexplain
especi
sinc
influenza
infect
usual
caus
viremia
viru
blood
spread
organ
number
unusu
symptom
myopathi
myocard
encephalopathi
occasion
associ
influenza
without
ration
explan
although
epidem
variat
diseas
syndrom
one
person
anoth
primarili
due
host
factor
sinc
viru
strain
infect
person
viral
gene
affect
virul
critic
respons
overal
natur
sever
epidemicspandem
basic
viral
gene
regul
tissu
tropism
replic
effici
cell
kill
abil
also
determin
virul
viru
strain
iv
virul
multigen
ie
determin
sever
viral
gene
exampl
ha
critic
virul
factor
variat
bind
effici
sa
cleavag
effici
antigen
epitop
cleavag
ha
host
proteas
critic
produc
infecti
viru
length
natur
amino
acid
connect
peptid
includ
presenc
multipl
basic
amino
aa
eg
arginin
lysin
affect
virul
na
also
import
determin
spread
viru
therefor
virul
furthermor
three
p
protein
np
also
affect
virul
although
pandem
epidem
caus
influenza
virus
influenza
b
epidem
uncommon
influenza
b
virus
common
children
young
adult
influenza
b
virus
produc
similar
symptom
although
influenza
b
infect
usual
milder
influenza
infect
howev
influenza
b
viru
also
caus
sever
even
fatal
ill
infect
influenza
c
viru
less
common
produc
milder
symptom
either
b
virus
progress
outcom
diseas
human
complic
process
base
viral
virul
also
host
respons
follow
viru
infect
initi
host
respons
product
interferon
like
slow
process
viru
replic
protein
iv
potent
tool
counteract
host
interferon
subsequ
induct
three
major
class
antibodi
igm
igg
iga
cytotox
cell
facilit
limit
diseas
promot
recoveri
igm
produc
primari
infect
subsequ
respons
limit
igg
iga
although
antibodi
gener
viral
compon
antibodi
ha
na
provid
protect
limit
viru
spread
recoveri
person
becom
solidli
immun
reinfect
iv
secretari
iga
nasal
respiratori
mucosa
effect
prevent
reinfect
humor
igg
ha
provid
neutral
antibodi
easili
assay
hemagglutin
inhibit
hi
antibodi
na
neutral
viru
prevent
viru
spread
infect
new
cellshost
cytotox
cell
gener
surfac
ha
intern
viral
compon
particularli
np
frequent
caus
complic
secondari
bacteri
infect
result
bacteri
pneumonia
pneumococci
haemophilu
influenza
staphylococci
frequent
isol
fatal
case
influenza
onset
bacteri
infect
usual
follow
symptom
viral
infect
subsid
accompani
return
sudden
chill
fever
product
cough
chest
pain
short
breath
bacteri
complic
common
patient
preexist
lung
condit
immunocompromis
patient
pneumonia
due
secondari
bacteri
complic
essenti
follow
cours
diseas
caus
bacteria
alon
appropri
antibiot
effect
bacteri
infect
uncommon
complic
enceph
mycocard
postinfect
neuriti
indistinguish
guillainbarr
syndrom
anoth
seriou
often
fatal
complic
call
rey
syndrom
implic
influenza
b
viru
rare
influenza
viru
varicella
chicken
pox
viru
along
aspirin
salicyl
medic
acut
noninflammatori
encephalopathi
cerebr
edema
accompani
fatti
degener
liver
onset
diseas
occur
within
day
infect
repeat
vomit
disorient
delirium
coma
diagnosi
base
clinic
symptom
alon
definit
differenti
iv
infect
similar
flulik
condit
unless
ongo
epidem
mani
virus
respiratori
syncyti
viru
adenovirus
coronavirus
rhinovirus
parainfluenzavirus
even
human
immunodefici
viru
caus
flulik
symptom
definit
virolog
diagnosi
done
laboratori
rapid
laboratori
diagnosi
specimen
collect
swab
posterior
pharynx
viral
antigen
detect
nasopharyng
cell
stain
antibodi
conjug
immunefluoresc
dye
swab
specimen
use
grow
viru
appropri
cell
cultur
mdck
cell
chicken
embryo
viru
detect
immunefluoresc
hemadsorpt
hemagglutin
specif
antibodi
intern
antigen
np
ml
use
determin
viru
type
ie
type
b
c
antibodi
ha
na
subtyp
specif
recent
newer
diagnost
assay
elisa
pcr
genom
sequenc
immunolog
molecular
biolog
tool
use
usual
virolog
diagnosi
carri
public
health
laboratori
import
determin
caus
natur
epidem
current
antiinfluenza
drug
limit
two
famili
base
either
interf
process
uncoat
rnpreleas
block
proton
channel
amantadin
rimantadin
prevent
spread
postbud
viru
particl
inhibit
enzymat
activ
na
oseltamivir
tamiflu
roch
zanamivir
relanza
glaxosmithklin
inhibitor
effect
influenza
na
inhibitor
effect
influenza
b
virus
drug
shown
benefici
reduc
intens
diseas
particularli
administ
earli
infect
use
chemoprophylact
agent
ongo
influenza
epidem
highrisk
group
nurs
home
environ
howev
chemoprophylaxi
substitut
vaccin
recommend
shortterm
prophylaxi
later
vaccin
highrisk
person
side
effect
drug
headach
confus
insomnia
slur
speech
addit
antivir
treatment
lead
emerg
drugresist
viru
strain
usual
influenza
short
ill
unev
recoveri
therefor
gener
support
treatment
recommend
case
includ
rest
light
diet
avoid
dehydr
symptomat
treatment
reduc
fever
suppress
cough
may
given
requir
secondari
bacteri
pneumonia
appropri
antibiot
use
addit
viral
bacteri
pneumonia
oxygen
therapi
may
need
reduc
hypoxemia
influenza
infect
lead
solid
immun
viru
mani
attempt
made
produc
safe
effect
vaccin
flu
epidem
current
cdc
recommend
two
type
vaccin
one
inactiv
whole
viru
vaccin
subunit
vaccin
also
call
split
viru
contain
compon
viral
envelop
ha
na
previous
unvaccin
children
subunit
vaccin
administr
twice
month
apart
intramuscularli
adult
children
vaccin
one
inject
recommend
vaccin
given
annual
flu
season
ie
earli
fall
immun
declin
year
follow
vaccin
live
attenu
vaccin
use
cold
adapt
viru
given
nasal
spray
effect
popul
protect
depend
age
immun
compet
vaccin
recipi
similar
vaccin
viru
circul
viru
good
match
vaccin
prevent
ill
vaccin
adult
year
old
among
elderli
person
nurs
home
vaccin
effect
prevent
mortal
even
though
effect
prevent
influenza
ill
among
frail
elderli
vaccin
also
play
import
role
reduc
spread
infect
nurs
home
herd
immun
effect
vaccin
viru
subtyp
epidem
viru
pose
logist
problem
vaccin
virus
next
fall
usual
select
public
health
author
earlier
spring
epidemiolog
criteria
viru
variant
circul
use
predict
next
year
epidem
strain
vaccin
strain
convert
highyield
viru
grow
chicken
embryo
reassort
highyield
viru
current
vaccin
whether
live
split
viru
produc
embryon
chicken
egg
although
epidem
viru
may
differ
vaccin
strain
vaccin
elicit
variantspecif
antibodi
vaccin
viru
heterovari
homosubtyp
antibodi
earlier
iv
infect
phenomenon
call
origin
antigen
sin
franci
due
amnest
respons
result
stimul
crossreact
memori
b
cell
hi
titer
provid
indic
protect
specif
subtyp
viru
effect
vaccin
must
produc
antibodi
ha
na
obtain
complet
unmodifi
viru
cytotox
tcell
respons
produc
ineffici
inactiv
subunit
vaccin
effici
live
attenu
vaccin
individu
chronic
diseas
may
develop
lower
antibodi
titer
nevertheless
even
individu
vaccin
effect
prevent
lower
respiratori
tract
infect
reduc
risk
pneumonia
hospit
death
antigen
drift
well
short
durat
humor
immun
induc
subunit
vaccin
requir
annual
vaccin
vaccin
whole
viru
sometim
produc
side
effect
includ
pain
site
inocul
febril
condit
subunit
vaccin
reduc
toxic
reaction
greatli
particularli
recommend
children
swine
influenza
campaign
guillambarr
syndrom
also
known
radiculoneur
acut
infect
polyneur
temporari
motor
weak
loss
reflex
unconfirm
complic
vaccin
inactiv
iv
vaccin
given
person
known
anaphylact
hypersensit
egg
person
acut
fever
recoveri
summari
current
vaccin
elicit
good
immun
respons
effect
reduc
morbid
mortal
target
group
recommend
target
group
resid
institut
elderli
peopl
disabl
elderli
noninstitution
individu
chronic
heart
lung
diseas
metabol
renal
diseas
immun
defici
individu
month
age
condit
list
elderli
individu
nation
defin
age
limit
irrespect
risk
factor
group
defin
basi
nation
data
capac
contact
highrisk
peopl
pregnant
women
health
care
worker
other
key
function
societi
well
children
month
age
common
tip
flu
prevent
follow
stay
home
flulik
symptom
least
h
fever
subsid
get
vaccin
talk
health
care
provid
wash
hand
least
cover
cough
sneez
elbow
hand
clean
work
area
disinfect
influenza
worldwid
infecti
viral
diseas
great
public
health
import
develop
develop
countri
caus
increas
morbid
mortal
popul
econom
impact
billion
dollar
recent
studi
molinari
et
al
estim
unit
state
alon
annual
influenza
epidem
result
approxim
lifeyear
lost
million
hospit
day
million
outpati
visit
result
medic
cost
billion
annual
accord
studi
lost
earn
due
ill
loss
life
amount
billion
annual
total
econom
burden
annual
influenza
epidem
amount
billion
also
unit
state
flu
season
usual
account
hospit
death
hospit
death
mainli
occur
highrisk
group
elderli
chronic
ill
worldwid
although
difficult
assess
annual
epidem
thought
result
million
case
sever
ill
death
everi
year
influenza
http
death
current
associ
influenza
industri
countri
occur
among
elderli
year
age
clearli
effect
drug
better
vaccin
need
combat
impact
flu
epidem
sinc
current
antiinfluenza
drug
limit
two
famili
name
proton
channel
blocker
na
inhibitor
virus
often
becom
resist
drug
better
understand
viru
life
cycl
could
provid
us
newer
viral
host
target
intervent
lead
develop
newer
therapeut
prophylact
agent
similarli
better
univers
vaccin
elicit
longlast
humor
cellular
immun
reduc
worldwid
impact
annual
epidem
infrequ
global
pandem
